# Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients

> **NCT03766321** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Azienda Ospedaliero-Universitaria di Modena** · enrollment: 42 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** Fecal microbiota transplantation
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03766321
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Modena
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-01
- **Primary completion:** 2024-10
- **Final completion:** 2025-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-08-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03766321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03766321, "Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03766321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*